GlobeNewswire·Nov 9, 2026, 4:10 PM ET

Surgery Partners, Inc. Announces Third Quarter 2026 Results

SGRY

Surgery Partners reported third quarter 2026 total revenues of $815.3 million, a 0.8% decrease year-over-year.
Same-facility revenues increased 6.0% in the third quarter 2026, driven by a 5.8% rise in revenue per case & a 0.2% increase in same-facility cases.
The company recorded a net loss attributable to Surgery Partners, Inc. of $21.1 million for the third quarter 2026.
Adjusted EBITDA for the third quarter 2026 was $132.7 million, down from $136.4 million in the prior year period.
Surgery Partners amended its merger agreement with HealthSpan Partners to increase consideration to $25.00 per share in cash, representing an enterprise value of up to $6.0 billion.
The amended agreement introduces a "Ticking Fee" paying 10% per annum on the merger consideration if the deal does not close by March 1, 2027.
The merger is expected to close in the first quarter of 2027, subject to stockholder approval & regulatory clearances.
Surgery Partners will not host an earnings conference call or provide forward-looking guidance due to the pending transaction.
Year-to-date 2026 revenues increased 2.1% to $2,475.1 million, while same-facility revenues rose 4.6%.
Year-to-date Adjusted EBITDA for 2026 was $360.2 million, compared to $369.3 million in the same period last year.
As of September 30, 2026, the company held $354.5 million in cash & cash equivalents with $692.8 million of borrowing capacity under its revolving credit facility.
The company's net debt to EBITDA ratio was approximately 4.4x at the end of the third quarter 2026.
Operating cash flows were $103.5 million for the third quarter 2026, compared to $83.6 million in the third quarter 2025.
The company operates 173 surgical facilities as of September 30, 2026.

Company: Surgery Partners, Inc.
Keywords: Nasdaq:SGRY, Surgery Partners, Inc.